Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| UG1EY036346 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Seva Foundation | OTHER |
| National Eye Institute (NEI) | NIH |
Not provided
Not provided
Not provided
Not provided
The goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye Worker II (VIEW II) trial who are referred to the eye hospital following eye disease screening. Participants who are referred to the hospital at an eye screening visit will be randomized to three different linkage-to-care interventions: (1) text message reminders, (2) reminders from health workers, or (3) no intervention. The primary outcome of the trial will be whether or not the participant presented to the eye hospital for a referral visit by 21 days following screening.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Text Message Reminders | Experimental |
| |
| Health Worker | Experimental |
| |
| No Intervention | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Text Message Reminder | Other | Participants referred to the eye hospital after screening will receive a text message reminding them to attend their referral visit. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Referral Visit Attendance | The count of participants who attend the referral visit. | 21 days after screening |
Not provided
Not provided
Inclusion Criteria:
- Participant of the VIEW II study referred to the eye hospital at their eye screening visit.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jeremy Keenan, MD, MPH | Contact | (415) 476-1442 | jeremy.keenan@ucsf.edu | |
| Krisianne Aromin | Contact | krisianne.aromin@ucsf.edu |
| Name | Affiliation | Role |
|---|---|---|
| Jeremy Keenan, MD, MPH | University of California, San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California, San Francisco | Recruiting | San Francisco | California | 94158 | United States |
De-identified data including age, cluster identifier, referral visit attendance
De-identified data will be shared after publication of the major findings of the study, which we anticipate will occur around 6 months after the study conclusion.
Other investigators can access the data if approved by the Trial Coordinating Center. Requests should be sent to the study contact(s).
Not provided
| ID | Term |
|---|---|
| D008268 | Macular Degeneration |
| D003930 | Diabetic Retinopathy |
| D005901 | Glaucoma |
| D005128 | Eye Diseases |
| D010349 | Patient Compliance |
| ID | Term |
|---|---|
| D012162 | Retinal Degeneration |
| D012164 | Retinal Diseases |
| D003925 | Diabetic Angiopathies |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Health Worker Visit | Other | Participants referred to the eye hospital after screening will receive a home visit from a health worker reminding them to attend their referral visit. |
|
| D002318 |
| Cardiovascular Diseases |
| D048909 | Diabetes Complications |
| D003920 | Diabetes Mellitus |
| D004700 | Endocrine System Diseases |
| D009798 | Ocular Hypertension |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |